XML 90 R74.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Deficit) - Common Stock Issuances (Details) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 21, 2024
May 03, 2024
Apr. 29, 2024
Aug. 15, 2023
Dec. 31, 2024
Nov. 30, 2024
Sep. 30, 2024
Aug. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Stockholders' Equity (Deficit)                        
Pursuant to the license and certain milestone achievements stock [1]                       $ 436,809
Pursuant to the Letter Agreement stock [2]                       $ 2,322,391
Number of common shares issued 160,624       137,500 112,500 107,875 160,624 94,697 40,297   653,493
Bausch License Agreement                        
Stockholders' Equity (Deficit)                        
Pursuant to the Letter Agreement shares   28,742                    
Pursuant to the Letter Agreement stock   $ 2,300,000                    
Bausch License Agreement | License                        
Stockholders' Equity (Deficit)                        
Pursuant to the Letter Agreement shares   28,742                    
Pursuant to the Letter Agreement stock   $ 2,300,000                    
Formosa Pharmaceuticals Inc | License                        
Stockholders' Equity (Deficit)                        
Pursuant to the license and certain milestone achievements issued     7,668 6,097                
Pursuant to the license and certain milestone achievements stock     $ 400,000                  
Merenti Management GmbH                        
Stockholders' Equity (Deficit)                        
Number of common shares issued                     14,882  
[1] Shares issued as partial consideration for License Agreement with Formosa Pharmaceuticals Inc.
[2] Shares issued as partial consideration for reversion of License Agreement with Bausch & Lomb Ireland Limited.